Expression of stromelysin-3 in medullary carcinoma of the breast

Anticancer Research

Volumn 17, Issue 5 B, 1997, Pages 3725-3727

  Holm, Ruth ^a   Flørenes, Vivi Ann ^a   Erikstein, Bjørn ^a   Nesland, Jahn M ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast; In situ hybridization; Medullary carcinomas; Stromelysin 3

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN; STROMELYSIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MEDULLARY CARCINOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, MEDULLARY; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 11; METALLOENDOPEPTIDASES; MIDDLE AGED; RNA; TUMOR MARKERS, BIOLOGICAL;

EID: 0031438465     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Moore OS Jr and Foote FW Jr: The relatively favorable prognosis of medullary carcinoma of the breast. Cancer 2: 635-642, 1949.
2. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC and Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704, 1990.
3. Basset P, Wolf C, Rouyer N, Bellocq J-P, Rio M-C and Chambon P: Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior. Cancer 74: 1045-1049, 1994.
4. Engel G, Heselmeyer K, Auer G, Backdahl M, Eriksson E and Linder S: Correlation between stromelysin-3 mRNA level and outcome of human breast cancer. Int J Cancer 58: 830-835, 1994.
5. Hähnel E, Dawkins H, Robbins P and Hähnel R: Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues. Int J Cancer 58: 157-160, 1994.
6. Hähnel E, Harvey JM, Joyce R, Robbins PD, Sterrett GF, and Hähnel R: Stromelysin-3 expression in breast cancer biopsies: Clinico-pathological correlations. Int J Cancer 55: 771-774, 1993.
7. Kawami H, Yoshida K, Ohsaki A, Kuroi K, Nishiyama M and Toge T: Stromelysin-3 mRNA expression and malignancy: Comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors. Anticancer Res 13: 2319-2324, 1993.
8. Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq J-P, Chambon P and Basset P: Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90: 1843-1847, 1993.
9. Ridolfi RL, Rosen PP, Port A, Kinne D and Mikè V: Medullary carcinoma of the breast. A clinicopathologic study with 10 year follow-up. Cancer 40: 1365-1385, 1977.
10. Holm R, Karlsen F and Nesland JM: In situ hybridization with nonisotopic probes using different detection systems. Mod Pathol 5: 315-319, 1992.
11. Bloom HJG, Richardson WW and Field JR: Host resistance and survival in carcinoma of the breast: A study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br J Med 3: 181-188, 1970.
12. Gaffey M, Frierson HF Jr, Mills SE, Boyd JC, Zarbo RJ, Simpson JF, Gross LK and-Weiss LM: Medullary Carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod Pathol 6: 721-728, 1993.
13. Liotta LA, Stetler-Stevenson WG and Steeg PS: Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 9: 543-551, 1991.
14. Matrisian LM: The matrix-degrading metalloproteinases. Bioessays 14: 455-463, 1992.
15. Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol 9: 541-573, 1993.
16. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG and Grigioni F: Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 4: 239-246, 1991.
17. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD and Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993.
18. Monteagudo C, Merino MJ, San-Juan J, Liotta LA and Stetler-Stevenson WG: Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol 136: 585-592, 1990.